Oxidative stress-dependent and -independent death of glioblastoma cells induced by non-thermal plasma-exposed solutions.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 09 2019
Historique:
received: 08 05 2019
accepted: 30 08 2019
entrez: 22 9 2019
pubmed: 22 9 2019
medline: 29 10 2020
Statut: epublish

Résumé

Non-thermal atmospheric pressure plasma has been widely used for preclinical studies in areas such as wound healing, blood coagulation, and cancer therapy. We previously developed plasma-activated medium (PAM) and plasma-activated Ringer's lactate solutions (PAL) for cancer treatments. Many in vitro and in vivo experiments demonstrated that both PAM and PAL exhibit anti-tumor effects in several types of cancer cells such as ovarian, gastric, and pancreatic cancer cells as well as glioblastoma cells. However, interestingly, PAM induces more intracellular reactive oxygen species in glioblastoma cells than PAL. To investigate the differences in intracellular molecular mechanisms of the effects of PAM and PAL in glioblastoma cells, we measured gene expression levels of antioxidant genes such as CAT, SOD2, and GPX1. Microarray and quantitative real-time PCR analyses revealed that PAM elevated stress-inducible genes that induce apoptosis such as GADD45α signaling molecules. PAL suppressed genes downstream of the survival and proliferation signaling network such as YAP/TEAD signaling molecules. These data reveal that PAM and PAL induce apoptosis in glioblastoma cells by different intracellular molecular mechanisms.

Identifiants

pubmed: 31541175
doi: 10.1038/s41598-019-50136-w
pii: 10.1038/s41598-019-50136-w
pmc: PMC6754505
doi:

Substances chimiques

Plasma Gases 0
Ringer's Lactate 0
CAT protein, human EC 1.11.1.6
Catalase EC 1.11.1.6
Glutathione Peroxidase EC 1.11.1.9
Superoxide Dismutase EC 1.15.1.1
superoxide dismutase 2 EC 1.15.1.1
Glutathione Peroxidase GPX1 EC 1.11.1.9
GPX1 protein, human EC 1.11.1.9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13657

Références

J Dtsch Dermatol Ges. 2010 Dec;8(12):968-76
pubmed: 20718902
Int J Oncol. 2015 Nov;47(5):1655-62
pubmed: 26351772
Biol Chem. 2018 Dec 19;400(1):87-91
pubmed: 30291778
J Mol Signal. 2008 Sep 12;3:15
pubmed: 18789159
Free Radic Biol Med. 2015 Feb;79:28-44
pubmed: 25433364
Fundam Clin Pharmacol. 2014 Apr;28(2):123-35
pubmed: 23432667
Front Immunol. 2017 Nov 27;8:1612
pubmed: 29230213
Mol Cell Biochem. 2007 Jun;300(1-2):77-87
pubmed: 17235455
Ophthalmologe. 1993 Dec;90(6):754-64
pubmed: 8124049
Cell Biosci. 2012 Jul 09;2(1):24
pubmed: 22769588
Br J Dermatol. 2010 Jul;163(1):78-82
pubmed: 20222930
Br J Cancer. 2011 Oct 25;105(9):1295-301
pubmed: 21979421
Gastric Cancer. 2015 Jul;18(3):635-43
pubmed: 24997570
Cancer Res. 2005 Sep 1;65(17):7573-9
pubmed: 16140920
Springerplus. 2014 Jul 31;3:398
pubmed: 25184103
Cell Signal. 2007 Apr;19(4):772-81
pubmed: 17127033
Cancer Res. 2004 Mar 15;64(6):1987-96
pubmed: 15026334
Sci Rep. 2016 May 13;6:26016
pubmed: 27172875
Ageing Res Rev. 2012 Jan;11(1):51-66
pubmed: 21986581
PLoS One. 2014 Jul 25;9(7):e103534
pubmed: 25062088
Neuropathology. 2009 Feb;29(1):20-4
pubmed: 18564103
Exp Cell Res. 2007 Feb 15;313(4):719-31
pubmed: 17182035
Sci Rep. 2016 Nov 08;6:36282
pubmed: 27824103
Cancer Biol Ther. 2008 Sep;7(9):1321-5
pubmed: 18836294
Arch Biochem Biophys. 2016 Sep 1;605:95-101
pubmed: 27033148
Appl Phys Lett. 2010 Apr 12;96(15):153704
pubmed: 20461224
Cancer Res. 2008 Apr 15;68(8):2895-903
pubmed: 18413758
Neuropharmacology. 2017 Apr;116:300-314
pubmed: 27986595
PLoS One. 2013 Dec 18;8(12):e81576
pubmed: 24367486
Sci Rep. 2017 Aug 8;7(1):7602
pubmed: 28790340
Med Device Technol. 1997 Jul-Aug;8(6):28-30
pubmed: 10169626
Zentralbl Hyg Umweltmed. 1993 Jul;194(4):380-91
pubmed: 8397686

Auteurs

Hiromasa Tanaka (H)

Center for Low-temperature Plasma Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8603, Japan. htanaka@plasma.engg.nagoya-u.ac.jp.
Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, 466-8550, Japan. htanaka@plasma.engg.nagoya-u.ac.jp.

Masaaki Mizuno (M)

Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, 466-8550, Japan.

Yuko Katsumata (Y)

Center for Low-temperature Plasma Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8603, Japan.

Kenji Ishikawa (K)

Center for Low-temperature Plasma Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8603, Japan.

Hiroki Kondo (H)

Center for Low-temperature Plasma Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8603, Japan.

Hiroshi Hashizume (H)

Center for Low-temperature Plasma Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8603, Japan.

Yasumasa Okazaki (Y)

Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Tsurumai-cho 65, Showa-ku, Nagoya, 466-8550, Japan.

Shinya Toyokuni (S)

Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Tsurumai-cho 65, Showa-ku, Nagoya, 466-8550, Japan.

Kae Nakamura (K)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-cho 65, Showa-ku, Nagoya, 466-8550, Japan.

Nobuhisa Yoshikawa (N)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-cho 65, Showa-ku, Nagoya, 466-8550, Japan.

Hiroaki Kajiyama (H)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-cho 65, Showa-ku, Nagoya, 466-8550, Japan.

Fumitaka Kikkawa (F)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-cho 65, Showa-ku, Nagoya, 466-8550, Japan.

Masaru Hori (M)

Center for Low-temperature Plasma Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8603, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH